Evidence map›Paper›PMID 31992597›Full record

ArticleThe Journal of biological chemistry2020

Nirwana Fitriani Walenna, Yusuke Kurihara, Bin Chou, Kazunari Ishii, Toshinori Soejima, Kenji Hiromatsu

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Observational
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Qingfei Tongluo Formula MitigatesDisease markers · 2022
    Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nirwana Fitriani WalennaDepartment of Microbiology & Immunology, Fukuoka University Faculty of Medicine, Fukuoka 814-0180, Japan; Department of Bacteriology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan.
Yusuke KuriharaDepartment of Microbiology & Immunology, Fukuoka University Faculty of Medicine, Fukuoka 814-0180, Japan.
Bin ChouDepartment of Microbiology & Immunology, Fukuoka University Faculty of Medicine, Fukuoka 814-0180, Japan.
Kazunari IshiiDepartment of Microbiology & Immunology, Fukuoka University Faculty of Medicine, Fukuoka 814-0180, Japan.
Toshinori SoejimaDepartment of Microbiology & Immunology, Fukuoka University Faculty of Medicine, Fukuoka 814-0180, Japan.
Kenji HiromatsuDepartment of Microbiology & Immunology, Fukuoka University Faculty of Medicine, Fukuoka 814-0180, Japan. Electronic address: khiromatsu@fukuoka-u.ac.jp.
Fukuoka University · JPKyushu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fatty acid-binding protein 4 (FABP4) is predominantly expressed in adipocytes and macrophages and regulates metabolic and inflammatory pathways. FABP4 is secreted from adipocytes during lipolysis, and elevated circulating FABP4 levels are associated with obesity, metabolic disease, and cardiac dysfunction. We previously reported that the bacterial respiratory pathogen

Indexed as

Endoplasmic Reticulum StressAdipocytesAdipose TissueAnimalsCalciumChlamydophila InfectionsFatty Acid-Binding ProteinsLipaseMetabolic SyndromeMiceReactive Oxygen SpeciesUnfolded Protein ResponseCalciumFabp4 protein, mouseFatty Acid-Binding ProteinsLipaseReactive Oxygen SpeciesadipocytebacteriaChlamydiaendoplasmic reticulum stress (ER stress)fatty acid binding proteininfectionlipolysismetabolic disorderoxidative stressunfolded protein response (UPR)

Identifiers

PMID31992597
PMCPMC7049972
OpenAlexW3003566985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.